Skip to content
value.today

Otonomy vs Vertex Pharmaceuticals Incorporated

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Vertex Pharmaceuticals Incorporated is the larger company by market value: $134.3 B against $113 M for Otonomy, 1188 times as much (market caps of Jan 7, 2022 for Otonomy and Oct 29, 2026 for Vertex Pharmaceuticals Incorporated). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • Vertex Pharmaceuticals Incorporated had more revenue: $12.0 B in the year to December 2025 against $0 M for Otonomy in the year to December 2020.
  • Vertex Pharmaceuticals Incorporated made a net profit of $4.0 B, while Otonomy made a net loss of $45 M.
  • Vertex Pharmaceuticals Incorporated keeps more of each dollar of sales: a net margin of 32.9% against -16555.6% for Otonomy.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0591171762352020202120222023202420252026Otonomy 77Vertex Pharmaceuticals Incorporated 235

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$3B$6B$9B$12B201720182019202020212022202320242025Vertex Pharmaceuticals Incorporated $12B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureOtonomy
OTIC
Vertex Pharmaceuticals Incorporated
VRTX · #171 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20081989
Size
Market cap$113 M*$134.3 B
Revenue$0 M$12.0 B
Net income$-45 M$4.0 B▲ best
Employees—6,400
Valuation
P/E ratio—33.8×
Price to sales—10.4×
Price to book—7.2×
Free cash flow yield—2.4%
Profitability
Gross margin—86.2%
Operating margin—34.8%
Net margin—32.9%
Return on equity—22.5%
Return on invested capital—26.2%
Growth
Revenue growth—8.9%
Revenue growth, 3 years a year—10.3%
Financial strength
Debt to equity—0.0×
Net debt to EBITDA—-1.2×
Cash
Free cash flow margin—26.6%
Shareholder returns
Shareholder yield—1.5%
Altman Z-score zone—safe
Data as ofMarket cap Jan 2022Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Otonomy or Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated is the larger company by market value: $134.3 B against $113 M for Otonomy, 1188 times as much (market caps of Jan 7, 2022 for Otonomy and Oct 29, 2026 for Vertex Pharmaceuticals Incorporated). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Otonomy or Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated had more revenue: $12.0 B in the year to December 2025 against $0 M for Otonomy in the year to December 2020. Vertex Pharmaceuticals Incorporated made a net profit of $4.0 B, while Otonomy made a net loss of $45 M.

Which is more profitable, Otonomy or Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated keeps more of each dollar of sales: a net margin of 32.9% against -16555.6% for Otonomy.

Sources#

Every figure on this page comes from these, with the date shown next to it.